“…A common evolutionary strategy, employed by many unicellular eukaryotic parasites, is expansive development of a family of surface proteins, which lie at the interface between host and parasite. Examples include PfEMP1 ( Leech et al., 1984 ), RIFIN ( Kyes et al., 1999 ), and STEVOR ( Cheng et al., 1998 ) of Plasmodium falciparum , VIR of P. vivax ( del Portillo et al., 2001 ), variant surface glycoproteins (VSGs) of Trypanosoma brucei ( Schwede and Carrington, 2010 ), MASP ( El-Sayed et al., 2005 ) and SAP ( Carmo et al., 2001 ) of Trypanosoma cruzi , and SAGs of Toxoplasma gondii ( Kasper et al., 1983 ). Expression switching between family members allows parasites to display a series of antigenically distinct surfaces, posing challenges for the immune system and for rational development of vaccines.…”